Your browser doesn't support javascript.
loading
Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes.
Alatrash, Gheath; Qiao, Na; Zhang, Mao; Zope, Madhushree; Perakis, Alexander A; Sukhumalchandra, Pariya; Philips, Anne V; Garber, Haven R; Kerros, Celine; St John, Lisa S; Khouri, Maria R; Khong, Hiep; Clise-Dwyer, Karen; Miller, Leonard P; Wolpe, Steve; Overwijk, Willem W; Molldrem, Jeffrey J; Ma, Qing; Shpall, Elizabeth J; Mittendorf, Elizabeth A.
Afiliação
  • Alatrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. galatras@mdanderson.org emittendorf@bwh.harvard.edu.
  • Qiao N; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zope M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Perakis AA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sukhumalchandra P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Philips AV; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garber HR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kerros C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • St John LS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khouri MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khong H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Clise-Dwyer K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Miller LP; Targazyme Inc., Carlsbad, California.
  • Wolpe S; Targazyme Inc., Carlsbad, California.
  • Overwijk WW; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Molldrem JJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ma Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mittendorf EA; Department of Surgical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. galatras@mdanderson.org emittendorf@bwh.harvard.edu.
Clin Cancer Res ; 25(8): 2610-2620, 2019 04 15.
Article em En | MEDLINE | ID: mdl-30647079

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Imunoterapia Adotiva / Epitopos de Linfócito T / Citotoxicidade Imunológica Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Imunoterapia Adotiva / Epitopos de Linfócito T / Citotoxicidade Imunológica Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article